OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

RNA-binding proteins tristetraprolin and human antigen R are novel modulators of podocyte injury in diabetic kidney disease
Jia Guo, M. Lei, Fei Cheng, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 6
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

HuR as a molecular target for cancer therapeutics and immune-related disorders
Mrinmoyee Majumder, Paramita Chakraborty, Sarumathi Mohan, et al.
Advanced Drug Delivery Reviews (2022) Vol. 188, pp. 114442-114442
Open Access | Times Cited: 57

Integrative biology of extracellular vesicles in diabetes mellitus and diabetic complications
Jing Liu, Yanyan Zhang, Yan Tian, et al.
Theranostics (2022) Vol. 12, Iss. 3, pp. 1342-1372
Open Access | Times Cited: 41

RNA-binding proteins and their role in kidney disease
Lisa Seufert, Thomas Benzing, Michael Ignarski, et al.
Nature Reviews Nephrology (2021) Vol. 18, Iss. 3, pp. 153-170
Closed Access | Times Cited: 35

Trimethylamine-N-Oxide Aggravates Kidney Injury via Activation of p38/MAPK Signaling and Upregulation of HuR
Yunshi Lai, Haie Tang, Xinrong Zhang, et al.
Kidney & Blood Pressure Research (2021) Vol. 47, Iss. 1, pp. 61-71
Open Access | Times Cited: 31

LncRNA AA465934 Improves Podocyte Injury by Promoting Tristetraprolin-Mediated HMGB1 DownRegulation in Diabetic Nephropathy
Nan Yang, Yue Zhang, Peiyao Ren, et al.
Molecular and Cellular Biology (2024) Vol. 44, Iss. 3, pp. 87-102
Closed Access | Times Cited: 3

Cell cycle disorders in podocytes: an emerging and increasingly recognized phenomenon
Chaojie Zhang, Jia Guo
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access

The intellectual base and global trends in inflammation of diabetic kidney disease: a bibliometric analysis
LuYao Shi, Chang‐Yan Li, Jian Wang, et al.
Renal Failure (2023) Vol. 45, Iss. 2
Open Access | Times Cited: 7

Advances in the study of RNA-binding proteins in diabetic complications
Xinyue Chen, Jiaqiang Wu, Zhangwang Li, et al.
Molecular Metabolism (2022) Vol. 62, pp. 101515-101515
Open Access | Times Cited: 12

GSK3β: A ray of hope for the treatment of diabetic kidney disease
Lulu Liang, Mengfei He, P. Zhou, et al.
The FASEB Journal (2024) Vol. 38, Iss. 3
Closed Access | Times Cited: 2

Global analysis of RNA–protein interactions in TNF‐α induced alternative splicing in metabolic disorders
Jiss Maria Louis, Arjun Agarwal, Raviprasad Aduri, et al.
FEBS Letters (2021) Vol. 595, Iss. 4, pp. 476-490
Open Access | Times Cited: 14

IL-6/STAT3 signaling activation exacerbates high fructose-induced podocyte hypertrophy by ketohexokinase-A-mediated tristetraprolin down-regulation
Jie Zhou, Jie Yang, Yumeng Wang, et al.
Cellular Signalling (2021) Vol. 86, pp. 110082-110082
Closed Access | Times Cited: 12

Cataloguing the phosphorylation sites of tristetraprolin (TTP): Functional implications for inflammatory diseases
Maria C. Rezcallah, Juhura G. Almazi, Alaina J. Ammit
Cellular Signalling (2020) Vol. 78, pp. 109868-109868
Closed Access | Times Cited: 12

Long Noncoding RNA ENSG00000254693 Promotes Diabetic Kidney Disease via Interacting with HuR
Qun Yu, Jiangong Lin, Qiqi Ma, et al.
Journal of Diabetes Research (2022) Vol. 2022, pp. 1-13
Open Access | Times Cited: 8

RNA‐binding proteins in diabetic microangiopathy
Chao Tu, Liangzhi Wang, Lan Wei
Journal of Clinical Laboratory Analysis (2022) Vol. 36, Iss. 5
Open Access | Times Cited: 8

Post-transcriptional control by RNA-binding proteins in diabetes and its related complications
Shiyu Zhang, Xiao-Hua Yang, Miao Jiang, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 8

RNA-binding proteins in metabolic-associated fatty liver disease (MAFLD): From mechanism to therapy
Jiawei Xu, Xingyu Liu, WU Shu-qin, et al.
BioScience Trends (2023) Vol. 17, Iss. 1, pp. 21-37
Open Access | Times Cited: 4

Repurposing Niclosamide to Modulate Renal RNA-Binding Protein HuR for the Treatment of Diabetic Nephropathy in db/db Mice
Lili Zhuang, Wenjing Liu, Xiao-Qing E. Tsai, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9651-9651
Open Access | Times Cited: 1

c‐Cbl induced podocin ubiquitination contributes to the podocytes injury in diabetic nephropathy
Lulu Liang, Mengfei He, P. Zhou, et al.
The FASEB Journal (2024) Vol. 38, Iss. 10
Closed Access

Identification of RNA-binding protein genes associated with renal rejection and graft survival
Zhaozhong Zhong, Yongrong Ye, Liubing Xia, et al.
Renal Failure (2024) Vol. 46, Iss. 2
Open Access

The association of RNA-binding protein Human antigen R with kidney clinicopathologic features and renal outcomes in patients with diabetic nephropathy
Jiaxin Dong, Simeng Liu, Qing Li, et al.
Diabetes Research and Clinical Practice (2022) Vol. 193, pp. 110142-110142
Closed Access | Times Cited: 2

A global analysis on the differential regulation of RNA binding proteins (RBPs) by TNF–α as potential modulators of metabolic syndromes
Jiss Maria Louis, Arjun Agarwal, Sukanta Mondal, et al.
BBA Advances (2021) Vol. 2, pp. 100037-100037
Open Access | Times Cited: 1

Serum S100A8/A9 and RNA-binding protein, tristetraprolin as prognostic markers of renal damage
Fatima Al-Zahra’a Mohammed Radhi, Anwar Jasib Almzaie, Mohauman Mohammed Majeed
Anaesthesia Pain & Intensive Care (2023) Vol. 27, Iss. 6, pp. 706-715
Open Access

Page 1 - Next Page

Scroll to top